Skip to main content

Meritxell Ventura Cots

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Meritxell Ventura Cots

Institutions of which they are part

Main researcher
Liver Diseases
Vall Hebron Institut de Recerca

Projects

Efectos de la infusión de albúmina en el episodio de encefalopatía hepática. Estudio aleatorio y multicéntrico en pacientes con cirrosis hepática

IP: Victor Manuel Vargas Blasco
Collaborators: Beatriz Minguez Rosique, Juli Alonso Farre, Meritxell Ventura Cots
Funding agency: Instituto de Salud Carlos III
Funding: 71390
Reference: PI070641
Duration: 01/01/2008 - 30/12/2011

Related news

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

Related professionals

Alba Torija Recasens

Alba Torija Recasens

Predoctoral researcher
Nephrology and kidney transplantation
Read more
Carmina Castellano Tejedor

Carmina Castellano Tejedor

Senior researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more
Concepció Jacobs Cachá

Concepció Jacobs Cachá

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Xavier Serra Ruiz

Xavier Serra Ruiz

Research technician
Physiology and Pathophysiology of the Digestive Tract
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.